ACC CardiaCast Podcast Por American College of Cardiology arte de portada

ACC CardiaCast

ACC CardiaCast

De: American College of Cardiology
Escúchala gratis

Acerca de esta escucha

This occasional series from the American College of Cardiology offers the latest in clinical education and features an exploration of current research and interviews with cardiovascular experts.American College of Cardiology Foundation. All rights reserved. Enfermedades Físicas Hygiene & Healthy Living
Episodios
  • SCAI 2025 Think Tank Session Highlights: Radiation Protection and Team Well-Being
    Jun 20 2025
    In this episode Drs. Poonam Velagapudi, Saraschandra Vallabhajosyula, and James Hermiller explore the critical topic of occupational safety in the cath lab. While healthcare providers focus on treating patients, their work environment can put their own health at risk—particularly long-term impact of wearing heavy lead protection. Drawing from discussions at the Society for Cardiovascular Angiography & Interventions (SCAI) 2025 Think Tank Sessions, the episode highlights data on lead-free and reduced-lead solutions aimed at preventing back pain and injury among cardiac catheterization operators. Tune in for a timely conversation on protecting the well-being of the heart team. Related References Strepkos D, Rempakos A, Alexandrou M, et al. How to Improve Radiation Protection in Interventional Cardiology Procedures. Circ Cardiovasc Interv. 2025;18(4):e014808. doi:10.1161/CIRCINTERVENTIONS.124.014808 Women in Innovations (WIN) Radiation Safety (SCAI website). 2025. Available at: https://scai.org/membership/career-development/women-innovations-win/win-radiation-safety . Accessed 06/17/25. SCAI Highlights Cath Lab Radiation and Orthopaedic Hazards (Cardiovascular News website). Available at: https://cardiovascularnews.com/scai-highlights-cath-lab-radiation-and-orthopaedic-hazards/. Accessed 06/17/25. Occupational Health Hazards in the Cardiac Catheterization Laboratory (SCAI website). 2025. Available at: https://scai.org/occupational-health-hazards-cardiac-catheterization-laboratory . Accessed 06/17/25. Subscribe to CardiaCast | Claim CME Credit
    Más Menos
    12 m
  • Conversations in Heart Failure “Extrapolate with Caution: A STEMI Shock Reality Check”
    Jun 6 2025
    In this episode, Drs. Jenna Skowronski, Francesco Castagna and Saraschandra Vallabhajosyula unpack how assumptions drawn from ST-segment elevation myocardial infarction (STEMI) data may be leading us astray in broader shock management—and what that means for patient outcomes, clinical decision-making, and future research. Why do we keep applying STEMI solutions to non-STEMI problems? Are we oversimplifying cardiogenic shock? And what does the real-world data actually tell us? Join us for a candid, fast-paced conversation that challenges dogma, calls for nuance, and might just change the way you approach shock. Related References: Møller JE, Engstrøm T, Jensen LO, et al. Microaxial Flow Pump or Standard Care in Infarct-Related Cardiogenic Shock. N Engl J Med. 2024;390(15):1382-1393. doi:10.1056/NEJMoa2312572. Kochar A, Vallabhajosyula S, John K, et al. Factors associated with acute limb ischemia in cardiogenic shock and downstream clinical outcomes: Insights from the Cardiogenic Shock Working Group. J Heart Lung Transplant. 2024;43(11):1846-1856. doi:10.1016/j.healun.2024.06.012. Subscribe to CardiaCast | Claim CME Credit
    Más Menos
    30 m
  • Pharmacologic Interventions to Lower hs-CRP
    May 26 2025
    n this episode, Drs. Brittany Weber and Michael Garshick discuss “Pharmacologic Interventions to Lower hs-CRP.” This podcast is part of the Inflammation in Cardiovascular Health: Raising Awareness of the Increasing Role of hs-CRP grant initiative.  Educational support for this initiative is provided by Novo Nordisk.  Click here to learn more. Related References: Nidorf SM, Fiolet ATL, Mosterd A, et al; LoDoCo2 Trial Investigators. Colchicine in Patients with Chronic Coronary Disease. N Engl J Med. 2020;383(19):1838-1847. Ridker PM. From CANTOS to CIRT to COLCOT to Clinic: Will All Atherosclerosis Patients Soon Be Treated With Combination Lipid-Lowering and Inflammation-Inhibiting Agents? Circulation. 2020;141(10):787-789. Ridker PM. From RESCUE to ZEUS: Will interleukin-6 inhibition with ziltivekimab prove effective for cardiovascular event reduction? Cardiovasc Res. 2021;117(11):e138-e140. Ridker PM, Bhatt DL, Pradhan AD, et al; PROMINENT, REDUCE-IT, and STRENGTH Investigators. Inflammation and cholesterol as predictors of cardiovascular events among patients receiving statin therapy: a collaborative analysis of three randomised trials. Lancet. 2023;401(10384):1293-1301. Ridker PM, Moorthy MV, Cook NR, et al. Inflammation, Cholesterol, Lipoprotein(a), and 30-Year Cardiovascular Outcomes in Women. N Engl J Med. 2024;391(22):2087-2097. Tardif JC, Kouz S, Waters DD, et al. Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction. N Engl J Med. 2019;381(26):2497-2505. Subscribe to CardiaCast
    Más Menos
    15 m
adbl_web_global_use_to_activate_webcro805_stickypopup
Todavía no hay opiniones